These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 10564534)

  • 1. Hepatic encephalopathy: An update of pathophysiologic mechanisms.
    Hazell AS; Butterworth RF
    Proc Soc Exp Biol Med; 1999 Nov; 222(2):99-112. PubMed ID: 10564534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of hepatic encephalopathy: update on molecular mechanisms.
    Butterworth RF
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S11-6. PubMed ID: 15025246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of cirrhosis III. Hepatic encephalopathy.
    Butterworth RF
    J Hepatol; 2000; 32(1 Suppl):171-80. PubMed ID: 10728803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.
    Albrecht J; Jones EA
    J Neurol Sci; 1999 Nov; 170(2):138-46. PubMed ID: 10617392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular aspects of hepatic encephalopathy].
    Márquez-Aguirre AL; Canales-Aguirre AA; Gómez-Pinedo U; Gálvez-Gastélum FJ
    Neurologia; 2010 May; 25(4):239-47. PubMed ID: 20609302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings.
    Butterworth RF
    Metab Brain Dis; 2001 Jun; 16(1-2):55-65. PubMed ID: 11726089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy.
    Butterworth RF; Spahr L; Fontaine S; Layrargues GP
    Metab Brain Dis; 1995 Dec; 10(4):259-67. PubMed ID: 8847990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current theories on the pathogenesis of hepatic encephalopathy.
    Mousseau DD; Butterworth RF
    Proc Soc Exp Biol Med; 1994 Sep; 206(4):329-44. PubMed ID: 7915420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered glial-neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy.
    Butterworth RF
    Neurochem Int; 2010 Nov; 57(4):383-8. PubMed ID: 20350577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of hepatic encephalopathy: a new look at ammonia.
    Butterworth RF
    Metab Brain Dis; 2002 Dec; 17(4):221-7. PubMed ID: 12602499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in expression of genes coding for key astrocytic proteins in acute liver failure.
    Desjardins P; Bélanger M; Butterworth RF
    J Neurosci Res; 2001 Dec; 66(5):967-71. PubMed ID: 11746425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal-systemic encephalopathy: a disorder of neuron-astrocytic metabolic trafficking.
    Butterworth RF
    Dev Neurosci; 1993; 15(3-5):313-9. PubMed ID: 7805584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited.
    Butterworth RF
    Metab Brain Dis; 2016 Dec; 31(6):1211-1215. PubMed ID: 26521983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for an astrocytic glutamate transporter deficit in hepatic encephalopathy.
    Chan H; Butterworth RF
    Neurochem Res; 1999 Nov; 24(11):1397-401. PubMed ID: 10555780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema.
    Sepehrinezhad A; Zarifkar A; Namvar G; Shahbazi A; Williams R
    Metab Brain Dis; 2020 Apr; 35(4):559-578. PubMed ID: 32146658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osmotic and oxidative/nitrosative stress in ammonia toxicity and hepatic encephalopathy.
    Görg B; Schliess F; Häussinger D
    Arch Biochem Biophys; 2013 Aug; 536(2):158-63. PubMed ID: 23567841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of astrocytes in hepatic encephalopathy.
    Norenberg MD
    Neurochem Pathol; 1987; 6(1-2):13-33. PubMed ID: 3306480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy.
    Butterworth RF
    Metab Brain Dis; 1998 Dec; 13(4):337-49. PubMed ID: 10206825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy.
    Ahboucha S; Butterworth RF
    Metab Brain Dis; 2007 Dec; 22(3-4):291-308. PubMed ID: 17823858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ammonia: key factor in the pathogenesis of hepatic encephalopathy.
    Butterworth RF; Giguère JF; Michaud J; Lavoie J; Layrargues GP
    Neurochem Pathol; 1987; 6(1-2):1-12. PubMed ID: 3306479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.